Vairavan Latha
SEC CIK 2065881 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | SVP CFO | 86.0K | — | $149.8K | 8 | 2025-05-06 | 2026-05-11 |
Most active insiders at ARQT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watanabe Todd | See Remarks, Dir | — | $5.32M |
| 2 | Welgus Howard G. | Dir | — | $2.43M |
| 3 | Matsuda Masaru | See Remarks | — | $2.21M |
| 4 | Burnett Patrick | See Remarks | — | $2.02M |
| 5 | Leonard Keith R | Dir | — | $997.1K |
| 6 | Curran Terrie | Dir | — | $984.0K |
| 7 | Edwards Larry Todd | See Remarks | — | $968.4K |
| 8 | Krishnamohan Neha | Dir | — | $939.5K |
| 9 | LIN SUE-JEAN | Dir | — | $898.5K |
| 10 | Gilbert Halley E | Dir | — | $455.5K |
| 11 | Vairavan Latha | SVP CFO | — | $148.5K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-05-13 19:43 | 2026-05-11 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | S - Sale | $21.05 | -435 | 86.0K | -0.5% | -$9,157 |
| T | 2026-05-06 18:13 | 2026-05-04 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | S - Sale | $23.61 | -1,341 | 86.4K | -2% | -$31.7K |
| DM | 2026-03-03 | 2026-03-02 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | S - Sale | $25.18 | -2,853 | 87.8K | -3% | -$71.8K |
| D | 2026-03-03 | 2026-02-27 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | A - Grant | $0.00 | +27.0K | 90.6K | +42% | $0 |
| 2026-02-04 | 2026-02-02 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | S - Sale | $25.50 | -1,320 | 63.6K | -2% | -$33.7K | |
| 2025-11-05 | 2025-11-03 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | S - Sale | $24.72 | -88 | 64.9K | -0.1% | -$2,175 | |
| 2025-08-05 | 2025-08-04 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | S - Sale | $14.33 | -89 | 65.0K | -0.1% | -$1,275 | |
| D | 2025-05-07 | 2025-05-06 | ARQT | Arcutis Biotherapeutics, Inc. | Vairavan Latha | SVP CFO | A - Grant | $0.00 | +20.0K | 65.1K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations